PAG
XLRN

Private Advisor Group’s Acceleron Pharma XLRN Stock Holding History

Private Advisor Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,974
Closed -$512K – 2236
2021
Q3 		$512K Buy
+2,974
New +$389K ﹤0.01% 1500

Private Advisor Group's XLRN Position: Q4 2021 in Review

Private Advisor Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,974 shares — an estimated $512K sold.

Private Advisor Group first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $512K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Private Advisor Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Private Advisor Group sold 2,974 Acceleron Pharma shares in Q4 2021, an estimated $512K.
  • Private Advisor Group first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Private Advisor Group's Acceleron Pharma position peaked at $512K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Private Advisor Group's 13F filing for Q4 2021, filed 10 Feb 2022.